Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genotype and Phenotype Predictors of Relapse of Graves’ Disease after Antithyroid Drug Withdrawal

12 Oct 2012

Abstract excerpt

BACKGROUND: For patients with Graves' disease (GD), the primary goal of antithyroid drug therapy is to temporarily restore the patient to the euthyroid state and wait for a subsequent remission of the disease. This study sought to identify the predictive markers for the relapse of disease. METHODS: To do this, we studied 262 GD patients with long enough follow-up after drug withdrawal to determine treatment...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diabetes and associated disorders
Share to T-cell and B-cell Immunology
Share to Thyroid Disorders and Treatments

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24783027
DOI: 10.1159/000342621

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 25 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genotype and Phenotype Predictors of Relapse of Graves’ Disease after Antithyroid Drug WithdrawalPMID 24783027Read ↗

Cytotoxic T lymphocyte-associated molecule-4 gene polymorphism and hyperthyroid Graves' disease relapse after antithyroid drug withdrawal: a follow-up study.Semantic proximity Read ↗

Cytotoxic T lymphocyte-associated molecule-4 polymorphism and relapse of Graves' hyperthyroidism after antithyroid withdrawal.Semantic proximity Read ↗

The predictive value of CTLA-4 and Tg polymorphisms in the recurrence of Graves' disease after antithyroid withdrawal.Semantic proximity Read ↗

Outcome of Graves’ Disease and Associated Genetic Predisposition: A Systematic Review of LiteratureSemantic proximity Read ↗

The Role of Cytotoxic T-lymphocyte-associated Protein 4 (CTLA-4) Gene, Thyroid Stimulating Hormone Receptor (TSHR) Gene and Regulatory T-cells as Risk Factors for Relapse in Patients with Graves Disease.Semantic proximity Read ↗

Recurrence of Graves' Disease: What Genetics of HLA and PTPN22 Can Tell Us.Semantic proximity Read ↗

Susceptible alleles of the CD40 and CTLA-4 genes are not associated with the relapse after antithyroid withdrawal in Graves' disease.Semantic proximity Read ↗

Genetic markers in diagnosis and prediction of relapse in Graves' disease.Semantic proximity Read ↗

The T393C polymorphism of the Galphas gene (GNAS1) is associated with the course of Graves' disease.Semantic proximity Read ↗

Certain HLA alleles are associated with stress-triggered Graves' disease and influence its course.Semantic proximity Read ↗

Remission of Graves' hyperthyroidism and A/G polymorphism at position 49 in exon 1 of cytotoxic T lymphocyte-associated molecule-4 gene.Semantic proximity Read ↗

[New perspectives for the diagnosis and prognosis of Graves' disease].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.